|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 9
Zeitschriftenartikel
Li, Minglun; Fan, Yourong; Trapp, Christian; Schmidt-Hegemann, Nina Sophie; Ma, Jing; Buchner, Alexander; Lu, Shun; Xu, Bin; Stief, Christian; Wang, Xuanbin; Zhou, Cheng; Belka, Claus und Rogowski, Paul
(2022):
Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy.
In: Clinical and Translational Radiation Oncology, Bd. 39, 100571
Lu, Shun; Wang, Shubin; Kim, Robert Y.; Zhang, Jiayu; Wang, Xianliang; Wang, Weidong; Zhu, Guiquan; Zhou, Jie; Tan, Yan; Tan, Mingyu; Li, Minglun; Yin, Gang; Li, Jie; Feng, Mei und Lang, Jinyi
(2022):
Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
In: BJOG, Bd. 130, Nr. 2: S. 231-237
Sun, Chang; Wang, Shubin; Ye, Wenjing; Wang, RanLin; Tan, Mingyu; Zhang, Hanyi; Zhou, Jie; Li, Minglun; Wei, Lichun; Xu, Peng; Zhu, Guiquan; Lang, Jinyi und Lu, Shun
(2022):
The Prognostic Value of Tumor Size, Volume and Tumor Volume Reduction Rate During Concurrent Chemoradiotherapy in Patients With Cervical Cancer.
In: Frontiers in Oncology, Bd. 12, 934110
Shi, Run; Wang, Xin; Wu, Yang; Xu, Bin; Zhao, Tianyu; Trapp, Christian; Wang, Xuanbin; Unger, Kristian; Zhou, Cheng; Lu, Shun; Buchner, Alexander; Schulz, Gerald Bastian; Cao, Fengjun; Belka, Claus; Su, Chuan; Li, Minglun und Shu, Yongqian
(2022):
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
In: Theranostics, Bd. 12, Nr. 9: S. 4181-4199
Shi, Run; Bao, Xuanwen; Unger, Kristian; Sun, Jing; Lu, Shun; Manapov, Farkhad; Wang, Xuanbin; Belka, Claus und Li, Minglun
(2021):
Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients.
In: Theranostics, Bd. 11, Nr. 10: S. 5061-5076
Solagna, Francesca; Tezze, Caterina; Lindenmeyer, Maja T.; Lu, Shun; Wu, Guochao; Liu, Shuya; Zhao, Yu; Mitchell, Robert; Meyer, Charlotte; Omairi, Saleh; Kilic, Temel; Paolini, Andrea; Ritvos, Olli; Pasternack, Arja; Matsakas, Antonios; Kylies, Dominik; Schulze zur Wiesch, Julian; Turner, Jan-Eric; Wanner, Nicola; Nair, Viji; Eichinger, Felix; Menon, Rajasree; Martin, Ina V.; Klinkhammer, Barbara M.; Hoxha, Elion; Cohen, Clemens D.; Tharaux, Pierre-Louis; Boor, Peter; Ostendorf, Tammo; Kretzler, Matthias; Sandri, Marco; Kretz, Oliver; Puelles, Victor G.; Patel, Ketan und Huber, Tobias B.
(2021):
Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
In: Journal of Clinical Investigation, Bd. 131, Nr. 11, e135821
Sun, Jing; Shi, Run; Zhang, Xiaowen; Fang, Da; Rauch, Josefine; Lu, Shun; Wang, Xuanbin; Kasmann, Lukas; Ma, Jing; Belka, Claus; Su, Chuan und Li, Minglun
(2021):
Characterization of immune landscape in papillary thyroid cancer reveals distinct tumor immunogenicity and implications for immunotherapy.
In: Oncoimmunology, Bd. 10, Nr. 1, e1964189
Shi, Run; Bao, Xuanwen; Sun, Jing; Lu, Shun; Belka, Claus 
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, Minglun
(2020):
Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes.
In: Clinical and Translational Medicine, Bd. 10, Nr. 5, e187
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-1287-7825 und Li, Minglun
(2020):
Tumor microenvironment characterization in head and neck squamous carcinoma reveals distinct genomic alterations and clinical outcomes.
In: Clinical and Translational Medicine, Bd. 10, Nr. 5, e187
[PDF, 2MB]
Shi, Run; Bao, Xuanwen; Rogowski, Paul; Schaefer, Christian; Schmidt-Hegemann, Nina-Sophie; Unger, Kristian; Lu, Shun; Sun, Jing; Buchner, Alexander; Stief, Christian; Belka, Claus und Li, Minglun
(2020):
Establishment and Validation of an Individualized Cell Cycle Process-Related Gene Signature to Predict Cancer-Specific Survival in Patients with Bladder Cancer.
In: Cancers, Bd. 12, Nr. 5, 1146